{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:29:35Z","timestamp":1791289775362,"version":"4.3.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1681\/asn.2013070796","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T00:54:29Z","timestamp":1395363269000},"page":"2053-2065","source":"Crossref","is-referenced-by-count":109,"title":["Complement Factor B Mutations in Atypical Hemolytic Uremic Syndrome\u2014Disease-Relevant or Benign?"],"prefix":"10.1681","volume":"25","author":[{"given":"Maria Chiara","family":"Marinozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Vergoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Rybkine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Bettoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastas","family":"Pashov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Cayla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Tabarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Jablonski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Hue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Noris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Halbwachs-Mecarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Donadelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Fremeaux-Bacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubka T.","family":"Roumenina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20230208","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome.","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"R2-21-20230208","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jim.2010.12.020","article-title":"Alternative complement pathway assessment in patients with atypical HUS.","volume":"365","author":"Roumenina","year":"2011","journal-title":"J Immunol Methods"},{"key":"R3-21-20230208","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2010030315","article-title":"Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome.","volume":"21","author":"Dragon-Durey","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R4-21-20230208","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"R5-21-20230208","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R6-21-20230208","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/ajt.12077","article-title":"Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.","volume":"13","author":"Le Quintrec","year":"2013","journal-title":"Am J Transplant"},{"key":"R7-21-20230208","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrneph.2010.155","article-title":"New insights into postrenal transplant hemolytic uremic syndrome.","volume":"7","author":"Zuber","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"R8-21-20230208","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/ndt\/gft340","article-title":"Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions.","volume":"28","author":"B\u00e9k\u00e1ssy","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R9-21-20230208","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.molimm.2006.10.005","article-title":"A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation.","volume":"44","author":"Nilsson","year":"2007","journal-title":"Mol Immunol"},{"key":"R10-21-20230208","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ki.2011.291","article-title":"Complement factor H variants I890 and L1007 while commonly associated with atypical hemolytic uremic syndrome are polymorphisms with no functional significance.","volume":"81","author":"Tortajada","year":"2012","journal-title":"Kidney Int"},{"key":"R11-21-20230208","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1016\/j.molimm.2007.01.036","article-title":"The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation.","volume":"44","author":"Kavanagh","year":"2007","journal-title":"Mol Immunol"},{"key":"R12-21-20230208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ki.2011.330","article-title":"Interpretation of genetic variants of uncertain significance in atypical hemolytic uremic syndrome.","volume":"81","author":"Kavanagh","year":"2012","journal-title":"Kidney Int"},{"key":"R13-21-20230208","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: A nationwide French series comparing children and adults.","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R14-21-20230208","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.molimm.2005.06.041","article-title":"Does complement factor B have a role in the pathogenesis of atypical HUS?","volume":"43","author":"Kavanagh","year":"2006","journal-title":"Mol Immunol"},{"key":"R15-21-20230208","doi-asserted-by":"crossref","first-page":"E1445","DOI":"10.1002\/humu.21256","article-title":"Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.","volume":"31","author":"Maga","year":"2010","journal-title":"Hum Mutat"},{"key":"R16-21-20230208","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1093\/ndt\/gfq010","article-title":"Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS).","volume":"25","author":"Westra","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R17-21-20230208","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.","volume":"104","author":"Goicoechea de Jorge","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-21-20230208","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R19-21-20230208","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood-2009-01-197640","article-title":"Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome.","volume":"114","author":"Roumenina","year":"2009","journal-title":"Blood"},{"key":"R20-21-20230208","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00467-009-1415-3","article-title":"A novel mutation in the complement factor B gene (CFB) and atypical hemolytic uremic syndrome.","volume":"25","author":"Tawadrous","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"R21-21-20230208","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1182\/blood-2013-03-492421","article-title":"Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome.","volume":"122","author":"Feng","year":"2013","journal-title":"Blood"},{"key":"R22-21-20230208","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.1195821","article-title":"Structures of C3b in complex with factors B and D give insight into complement convertase formation.","volume":"330","author":"Forneris","year":"2010","journal-title":"Science"},{"key":"R23-21-20230208","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nsmb1210","article-title":"Factor B structure provides insights into activation of the central protease of the complement system.","volume":"14","author":"Milder","year":"2007","journal-title":"Nat Struct Mol Biol"},{"key":"R24-21-20230208","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ni.1756","article-title":"Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.","volume":"10","author":"Rooijakkers","year":"2009","journal-title":"Nat Immunol"},{"key":"R25-21-20230208","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1073\/pnas.0812584106","article-title":"Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B.","volume":"106","author":"Montes","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R26-21-20230208","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nmeth.1974","article-title":"The 1000 Genomes Project: Data management and community access.","volume":"9","author":"Clarke","year":"2012","journal-title":"Nat Methods"},{"key":"R27-21-20230208","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.imbio.2012.08.016","article-title":"A user-friendly method to study the effect of FH and impact of FB variants on C3bBb convertase and C3bB proconvertase formation.","volume":"217","author":"Bettoni","year":"2012","journal-title":"Immunobiology"},{"key":"R28-21-20230208","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.4049\/jimmunol.162.5.2906","article-title":"Mutations of the type A domain of complement factor B that promote high-affinity C3b-binding.","volume":"162","author":"Hourcade","year":"1999","journal-title":"J Immunol"},{"key":"R29-21-20230208","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1182\/blood-2011-10-383281","article-title":"A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function.","volume":"119","author":"Roumenina","year":"2012","journal-title":"Blood"},{"key":"R30-21-20230208","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF02289113","article-title":"Time-limit tests: Estimating their reliability and degree of speeding.","volume":"16","author":"Cronbach","year":"1951","journal-title":"Psychometrika"},{"key":"R31-21-20230208","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.4049\/jimmunol.0804031","article-title":"The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.","volume":"182","author":"Ferreira","year":"2009","journal-title":"J Immunol"},{"key":"R32-21-20230208","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.1074\/jbc.M900814200","article-title":"Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.","volume":"284","author":"Lehtinen","year":"2009","journal-title":"J Biol Chem"},{"key":"R33-21-20230208","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI16651","article-title":"Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome.","volume":"111","author":"Manuelian","year":"2003","journal-title":"J Clin Invest"},{"key":"R34-21-20230208","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-62703-724-2_19","article-title":"Functional evaluation of factor H genetic and acquired abnormalities: Application for atypical hemolytic uremic syndrome (aHUS).","volume":"1100","author":"Roumenina","year":"2014","journal-title":"Methods Mol Biol"},{"key":"R35-21-20230208","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.molimm.2004.01.003","article-title":"Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H.","volume":"41","author":"S\u00e1nchez-Corral","year":"2004","journal-title":"Mol Immunol"},{"key":"R36-21-20230208","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ni.1755","article-title":"Structure of complement fragment C3b-factor H and implications for host protection by complement regulators.","volume":"10","author":"Wu","year":"2009","journal-title":"Nat Immunol"},{"key":"R37-21-20230208","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.molimm.2011.11.003","article-title":"Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS.","volume":"49","author":"Ermini","year":"2012","journal-title":"Mol Immunol"},{"key":"R38-21-20230208","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.","volume":"24","author":"Bresin","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R39-21-20230208","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis.","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"R40-21-20230208","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations.","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"key":"R41-21-20230208","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jmg.2005.033878","article-title":"Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral.","volume":"43","author":"Tavtigian","year":"2006","journal-title":"J Med Genet"},{"key":"R42-21-20230208","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nmeth0810-575","article-title":"MutationTaster evaluates disease-causing potential of sequence alterations.","volume":"7","author":"Schwarz","year":"2010","journal-title":"Nat Methods"},{"key":"R43-21-20230208","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm.","volume":"4","author":"Kumar","year":"2009","journal-title":"Nat Protoc"},{"key":"R44-21-20230208","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2013-03-489245","article-title":"Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.","volume":"122","author":"Frimat","year":"2013","journal-title":"Blood"},{"key":"R45-21-20230208","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00467-013-2492-x","article-title":"Eculizumab therapy for atypical haemolytic uraemic syndrome due to a gain-of-function mutation of complement factor B.","volume":"28","author":"Gilbert","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"R46-21-20230208","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ki.2009.472","article-title":"Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome.","volume":"77","author":"Bienaime","year":"2010","journal-title":"Kidney Int"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201409000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:26:18Z","timestamp":1786130778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201409000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2013070796","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}